Alois Niederhauser

Title: The Innovations of Alois Niederhauser

Introduction

Alois Niederhauser is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of circulatory disorders. His innovative approach has led to the development of a unique patent that addresses important medical needs.

Latest Patents

Alois Niederhauser holds a patent for the use of etilefrin and etilefrin pivalate in the long-term treatment of circulatory disorders not due to hypotonia. This patent highlights the surprising effects of etilefrin or etilefrin pivalate, which lead to a continuous stable rise in systolic blood pressure and blood pressure amplitude, as well as improved cardiac output. Notably, this treatment does not affect diastolic blood pressure or cardiac frequency. The pharmaceutical effect is further enhanced when etilefrin is combined with an extract of horse chestnut seeds for long-term treatment.

Career Highlights

Alois Niederhauser is associated with Klinge Pharma GmbH, where he continues to innovate in the pharmaceutical industry. His work has been instrumental in advancing treatments for patients with circulatory issues, showcasing his commitment to improving healthcare outcomes.

Collaborations

Alois has collaborated with Klaus Seibel, contributing to the development of effective pharmaceutical solutions. Their partnership exemplifies the importance of teamwork in the field of innovation.

Conclusion

Alois Niederhauser's contributions to the pharmaceutical industry through his patent and collaborative efforts demonstrate his dedication to advancing medical treatments. His work continues to impact the lives of many individuals suffering from circulatory disorders.